Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Sems Lloyd, Director. Insider active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 2 filings have been logged. History available since 15 June 2021. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Lloyd Sems is a Director at Cyclacel Pharmaceuticals, Inc. In this role, he participates in the governance of the company and strategic decision-making. Lloyd brings his expertise and advice to help guide Cyclacel's direction, ensuring that the company meets its objectives and commitments to its stakeholders.